BioCentury
ARTICLE | Clinical News

NNZ-2566: Phase II start

May 14, 2007 7:00 AM UTC

Next half, NEU will begin a placebo-controlled, Australian and New Zealand Phase II trial in 60-70 patients to evaluate a bolus of NNZ-2566 followed by an IV infusion for 12-24 hours. ...